CN105029553A - 一种果汁蛋钙中药保健饮料及其制备方法 - Google Patents
一种果汁蛋钙中药保健饮料及其制备方法 Download PDFInfo
- Publication number
- CN105029553A CN105029553A CN201510325950.6A CN201510325950A CN105029553A CN 105029553 A CN105029553 A CN 105029553A CN 201510325950 A CN201510325950 A CN 201510325950A CN 105029553 A CN105029553 A CN 105029553A
- Authority
- CN
- China
- Prior art keywords
- parts
- fruit
- kilograms
- egg
- vinegar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013399 edible fruits Nutrition 0.000 title claims abstract description 93
- 239000011575 calcium Substances 0.000 title claims abstract description 47
- 229910052791 calcium Inorganic materials 0.000 title claims abstract description 47
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 230000036541 health Effects 0.000 title abstract description 15
- 235000013361 beverage Nutrition 0.000 title abstract description 6
- 235000013601 eggs Nutrition 0.000 claims abstract description 87
- 239000000052 vinegar Substances 0.000 claims abstract description 51
- 235000021419 vinegar Nutrition 0.000 claims abstract description 51
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 38
- 235000009508 confectionery Nutrition 0.000 claims abstract description 28
- 235000012907 honey Nutrition 0.000 claims abstract description 27
- 239000002994 raw material Substances 0.000 claims abstract description 23
- 239000000463 material Substances 0.000 claims abstract description 22
- 229930006000 Sucrose Natural products 0.000 claims abstract description 21
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 21
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 19
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 19
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 19
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 19
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 19
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 19
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 19
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 19
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 19
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 19
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 19
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 19
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 19
- 244000185386 Thladiantha grosvenorii Species 0.000 claims abstract description 19
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims abstract description 19
- 229960003080 taurine Drugs 0.000 claims abstract description 19
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 18
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 18
- 244000241872 Lycium chinense Species 0.000 claims abstract description 18
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 18
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 17
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 17
- 239000000843 powder Substances 0.000 claims abstract description 16
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims abstract description 15
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 15
- 239000004302 potassium sorbate Substances 0.000 claims abstract description 15
- 235000010241 potassium sorbate Nutrition 0.000 claims abstract description 15
- 229940069338 potassium sorbate Drugs 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 45
- 230000001954 sterilising effect Effects 0.000 claims description 43
- 239000007788 liquid Substances 0.000 claims description 29
- 239000000203 mixture Substances 0.000 claims description 25
- 235000015203 fruit juice Nutrition 0.000 claims description 23
- 239000000284 extract Substances 0.000 claims description 18
- 241000271566 Aves Species 0.000 claims description 16
- 240000006365 Vitis vinifera Species 0.000 claims description 16
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 16
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 15
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 15
- 238000000855 fermentation Methods 0.000 claims description 14
- 230000004151 fermentation Effects 0.000 claims description 14
- 244000000626 Daucus carota Species 0.000 claims description 13
- 235000002767 Daucus carota Nutrition 0.000 claims description 13
- 241001672694 Citrus reticulata Species 0.000 claims description 12
- 238000007796 conventional method Methods 0.000 claims description 12
- 102000002322 Egg Proteins Human genes 0.000 claims description 11
- 108010000912 Egg Proteins Proteins 0.000 claims description 11
- 210000003278 egg shell Anatomy 0.000 claims description 11
- 239000000047 product Substances 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 10
- 244000288157 Passiflora edulis Species 0.000 claims description 9
- 235000000370 Passiflora edulis Nutrition 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 240000006063 Averrhoa carambola Species 0.000 claims description 8
- 235000010082 Averrhoa carambola Nutrition 0.000 claims description 8
- 239000000084 colloidal system Substances 0.000 claims description 6
- 230000008030 elimination Effects 0.000 claims description 6
- 238000003379 elimination reaction Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 240000007594 Oryza sativa Species 0.000 claims description 4
- 235000007164 Oryza sativa Nutrition 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims description 3
- 235000021552 granulated sugar Nutrition 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 41
- 210000004369 blood Anatomy 0.000 abstract description 22
- 239000008280 blood Substances 0.000 abstract description 22
- 210000004185 liver Anatomy 0.000 abstract description 14
- 235000016709 nutrition Nutrition 0.000 abstract description 11
- 206010028980 Neoplasm Diseases 0.000 abstract description 7
- 230000035764 nutrition Effects 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 210000004556 brain Anatomy 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 5
- 230000036772 blood pressure Effects 0.000 abstract description 5
- 230000004304 visual acuity Effects 0.000 abstract description 5
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 206010003210 Arteriosclerosis Diseases 0.000 abstract description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract description 2
- 241000700605 Viruses Species 0.000 abstract description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 abstract 1
- 230000003014 reinforcing effect Effects 0.000 abstract 1
- 230000009758 senescence Effects 0.000 abstract 1
- 230000003867 tiredness Effects 0.000 abstract 1
- 208000016255 tiredness Diseases 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 229940116269 uric acid Drugs 0.000 abstract 1
- 235000001465 calcium Nutrition 0.000 description 30
- 241001570521 Lonicera periclymenum Species 0.000 description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 13
- 210000004072 lung Anatomy 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 229930003231 vitamin Natural products 0.000 description 10
- 235000013343 vitamin Nutrition 0.000 description 10
- 239000011782 vitamin Substances 0.000 description 10
- 229940088594 vitamin Drugs 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 9
- 206010012735 Diarrhoea Diseases 0.000 description 9
- 230000001093 anti-cancer Effects 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 238000011161 development Methods 0.000 description 8
- 230000018109 developmental process Effects 0.000 description 8
- 235000019640 taste Nutrition 0.000 description 8
- 150000003722 vitamin derivatives Chemical class 0.000 description 8
- 150000007524 organic acids Chemical class 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 229910052742 iron Inorganic materials 0.000 description 6
- 229960003284 iron Drugs 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- -1 carrotene Proteins 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 229930182478 glucoside Natural products 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- 208000034189 Sclerosis Diseases 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 150000008131 glucosides Chemical class 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 235000014786 phosphorus Nutrition 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 229960004106 citric acid Drugs 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 229940099690 malic acid Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 235000008935 nutritious Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 235000019605 sweet taste sensations Nutrition 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- XXLFLUJXWKXUGS-UHFFFAOYSA-N 6-methoxyquinoline-4-carboxylic acid Chemical compound N1=CC=C(C(O)=O)C2=CC(OC)=CC=C21 XXLFLUJXWKXUGS-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 239000001263 FEMA 3042 Substances 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 241000607764 Shigella dysenteriae Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- LRBQNJMCXXYXIU-QWKBTXIPSA-N gallotannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-QWKBTXIPSA-N 0.000 description 2
- 235000019674 grape juice Nutrition 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 229940116315 oxalic acid Drugs 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 235000015523 tannic acid Nutrition 0.000 description 2
- 229940033123 tannic acid Drugs 0.000 description 2
- 229920002258 tannic acid Polymers 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 229950002929 trinitrophenol Drugs 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- TWNIBLMWSKIRAT-RWOPYEJCSA-N (1r,2s,3s,4s,5r)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol Chemical compound O1[C@@]2([H])OC[C@]1([H])[C@@H](O)[C@H](O)[C@@H]2O TWNIBLMWSKIRAT-RWOPYEJCSA-N 0.000 description 1
- WRPAFPPCKSYACJ-ZBYJYCAASA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8r,9r,10s,11r,13r,14s,17r)-17-[(5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-hydroxy-6-methylheptan-2-yl]-11-hydrox Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H](CCC(C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@@H]3[C@]2(C)CC1)C)C(C)(C)O)[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O WRPAFPPCKSYACJ-ZBYJYCAASA-N 0.000 description 1
- GHBNZZJYBXQAHG-KUVSNLSMSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8s,9r,10r,11r,13r,14s,17r)-17-[(2r,5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GHBNZZJYBXQAHG-KUVSNLSMSA-N 0.000 description 1
- STGNLGBPLOVYMA-MAZDBSFSSA-N (E)-but-2-enedioic acid Chemical compound OC(=O)\C=C\C(O)=O.OC(=O)\C=C\C(O)=O STGNLGBPLOVYMA-MAZDBSFSSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical group Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- WRYLYDPHFGVWKC-SNVBAGLBSA-N 4-Terpineol Natural products CC(C)[C@]1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-SNVBAGLBSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241001131796 Botaurus stellaris Species 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000175212 Herpesvirales Species 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003005 anti-senility effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000012550 audit Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- BHLWLVTYEDJFGZ-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1.O=CC1=CC=CC=C1 BHLWLVTYEDJFGZ-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- OVYQSRKFHNKIBM-UHFFFAOYSA-N butanedioic acid Chemical compound OC(=O)CCC(O)=O.OC(=O)CCC(O)=O OVYQSRKFHNKIBM-UHFFFAOYSA-N 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical class OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004320 controlled atmosphere Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000003648 hair appearance Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- KYYWBEYKBLQSFW-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O KYYWBEYKBLQSFW-UHFFFAOYSA-N 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229930191869 mogroside IV Natural products 0.000 description 1
- OKGRRPCHOJYNKX-UHFFFAOYSA-N mogroside IV A Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O OKGRRPCHOJYNKX-UHFFFAOYSA-N 0.000 description 1
- WRPAFPPCKSYACJ-UHFFFAOYSA-N mogroside IV E Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O WRPAFPPCKSYACJ-UHFFFAOYSA-N 0.000 description 1
- TVJXHJAWHUMLLG-UHFFFAOYSA-N mogroside V Natural products CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(O)C3O)C(O)C(O)C1O)C(C)(C)O)C4CCC5(C)C6CC=C7C(CCC(OC8OC(COC9OC(CO)C(O)C(O)C9O)C(O)C(O)C8O)C7(C)C)C6(C)C(O)CC45C TVJXHJAWHUMLLG-UHFFFAOYSA-N 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明为一种果汁蛋钙中药保健饮料及其制备方法，由水果、禽蛋、中药及辅料制成，所述水果的重量份数为10-15份，所述禽蛋的重量份数为11-13份；中药的重量份数分别为：绞股蓝1-2份、山楂叶2-3份、淮山3-5份、枸杞子1-1.5份、红枣1.8-2份、陈皮1-2份、罗汉果2.2-2.4份、龙眼肉1.8-2份、金银花1.8-2份、银杏叶3-5份；辅料的重量份数分别为：果醋6-8份、白糖14-16份、蜜糖1.8-2份、牛磺酸1.8-2份、山梨酸钾0.45-0.5份、干酵母0.4-0.6份、甜酒粉0.1-0.3份、灭菌泉水15-35份。本保健饮料营养丰富，酸甜可口，集保健和营养于一体，对养肝明目、活血化淤、健脑益智、保护肝脏、防治动脉硬化、抗病毒、延缓衰老、消除疲劳、降血压、降血脂、降尿酸、防癌抗癌起到积极的作用，具有较好的经济效益、社会效益。
Description
技术领域
本发明涉及一种保健饮料，特别是一种以新鲜生榨果汁、蛋钙液、中药提取液混合制得的保健饮料及其制备方法。
背景技术
目前，市场上销售的饮料有很多种，如加汽碳酸饮料、果汁饮料、保健茶饮料、中药保健饮料、功能性保健饮料、运动饮料等，这些饮料对丰富人们的生活、促进人体健康起到较大作用。从许多文献资料中我们可以了解到，水果中富含多种有机酸如苹果酸、柠檬酸、酒石酸、奎宁酸、鞣酸、单宁酸、尼克酸、水杨酸等，还含有人体必需的多种维生素如维生素B、维生素C、胡萝卜素以及纤维素、果糖、糖苷、淀粉、矿物质、微量元素等，经常吃水果可以补充每日三餐以外的营养成分。此外，据资料显示，用米醋浸蛋制成“保健醋蛋液”是我国民间用来防治疾病的传统经验疗法，对内科、外科、皮肤科等一百多种常见病有不同程度的疗效。现代医学研究表明，果醋中含有醋酸，可将蛋壳的不溶性钙变为可溶性、易吸收的醋酸钙，添加的酵母粉及甜酒粉还可将蛋中长链蛋白质分解成短链蛋白质，可溶于水，易于人体吸收。资料显示，醋蛋可调整与弥补人体营养状况，改善和提高新陈代谢水平，有助于机体内的细胞再生、分裂、软化血管，增进血液循环，有利于体内基础代谢和物质代谢的正常运行，增强体质，提高抗病、免疫、延缓衰老等防治疾病的功能，对高血压、脑血栓后遗症、冠心病、心绞痛、胆囊炎、气管炎、风湿痛、失眠、便秘、胃下垂、肩周炎、糖尿病等效果较显著。
发明内容
本发明的目的是根据水果、果醋蛋的营养成分，以及中药保健的特点，进行科学配伍、合理调配，制成一种果汁蛋钙中药保健饮料。
为了实现上述目的，本发明采用了以下技术方案：
一种果汁蛋钙中药保健饮料，主要由水果、禽蛋、中药及辅料制成，所述水果的重量份数为10-15份，所述禽蛋的重量份数为11-13份，所述中药的重量份数分别为：绞股蓝1-2份、山楂叶2-3份、淮山3-5份、枸杞子1-1.5份、红枣1.8-2份、陈皮1-2份、罗汉果2.2-2.4份、龙眼肉1.8-2份、金银花1.8-2份、银杏叶3-5份，所述辅料的重量份数分别为：果醋6-8份、白糖14-16份、蜜糖1.8-2份、牛磺酸1.8-2份、山梨酸钾0.45-0.5份、干酵母0.4-0.6份、甜酒粉0.1-0.3份、灭菌泉水15-35份。
进一步地，所述的一种果汁蛋钙中药保健饮料，其原料组分和重量份数为：水果13份、禽蛋12份、绞股蓝1.5份、山楂叶2.5份、淮山4份、枸杞子1.3份、红枣1.9份、陈皮1.5份、罗汉果2.3份、龙眼肉1.9份、金银花1.9份、银杏叶4份、果醋7份、白糖15份、蜜糖1.9份、牛磺酸1.9份、山梨酸钾0.48份、干酵母0.5份、甜酒粉0.2份、灭菌泉水25份。
进一步地，所述水果为葡萄、百香果、酸梅、杨桃、皇帝柑、胡萝卜一种以上。
进一步地，所述果醋为市售果醋或自制的果醋。
进一步地，所述禽蛋为新鲜鸡蛋、海鸭蛋。
进一步地，果汁蛋钙中药保健饮料的制备方法，先将所述的原料组分和重量份数分类制成蛋钙液、中药提取液和鲜果汁，将蛋钙液、中药提取液和鲜果汁合并，再加入白糖14-16份、蜜糖1.8-2份、牛磺酸1.8-2份、山梨酸钾0.45-0.5份，搅拌溶解，再加入余下的灭菌泉水，搅匀，经胶体磨均质，常规方法灭菌，过滤，分装即得到果汁蛋钙中药保健饮料产品。
进一步地，所述蛋钙液的制备方法是将11-13份禽蛋洗净，再将禽蛋打烂，禽蛋液打散备用，将禽蛋壳捻碎加入果醋2-3份，待蛋壳醋渍24小时后，加入蛋液和干酵母0.1-0.2份，拌匀，发酵后，在121℃高压灭菌30min，取出用匀浆机掏碎，再加入果醋4-5份、适量灭菌泉水及干酵母0.2-0.4份，拌匀，封盖，控制温度40℃，发酵48小时后，加入甜酒粉0.1-0.3份，拌匀，继续在40℃温度下发酵48-72小时，过滤，得到蛋钙液。
进一步地，所述中药提取液的制备方法是将绞股蓝1-2份、山楂叶2-3份、淮山3-5份、枸杞子1-1.5份、红枣1.8-2份、陈皮1-2份、罗汉果2.2-2.4份、龙眼肉1.8-2份、金银花1.8-2份、银杏叶3-5份分别去杂，水洗，切碎，加入原料组分总重量的6-8倍灭菌泉水，在蒸煮罐中煎煮1-2小时后过滤，药渣加入原料组分总重量的3-5倍灭菌泉水复煮1-2小时后过滤，合并滤液，按常规方法浓缩至0.5-1倍药材量，放置沉淀槽中静置过夜，取上清液得到中药提取液。
进一步地，所述鲜果汁的制备方法是将葡萄、百香果、酸梅、杨桃、皇帝柑、胡萝卜等一种以上共10-15份，洗净，除去泥沙等杂物，再用螺杆挤压机绞碎成果泥，加入灭菌泉水10-12份，搅匀，高速离心机120目过滤，得到鲜果汁。
进一步地，所述自制果醋的制备方法是将苹果1份洗净，沥干水分，切成小块，置干净玻璃瓶中，加砂糖0.5份及糯米醋0.5份，摇匀，密封置于阴凉干燥处，一周后取出，用100目滤布过滤即得自制苹果醋。
以上所述原料组分的功能及药理：
1、绞股蓝：绞股蓝(FiveleafGynostemmaHerb)被誉为“第二人参”，它的主要功能有：能防止动脉粥样硬化，降血压，降血脂，降血糖；抗动脉硬化、抑制血栓形成，治疗心血管疾病；抗癌防癌，抑制杀灭癌细胞；增强人体的免疫功能。
2、山楂叶：山楂叶即为山楂树的叶，山楂叶中含有丰富的人体必需的氨基酸、矿物质和维生素，其主要化学成分是总黄酮，能防治心血管疾病，具有扩张血管、增加冠脉血流量、改善心脏活力、兴奋中枢神经系统、降低血压和胆固醇、软化血管及利尿和镇静的功效；并有开胃消食、加强对营养的运输、活血化淤、平喘化痰、抑制细菌、治疗腹痛腹泻的作用；其所含的总黄酮和维生素C、胡萝卜素等物质能阻断并减少自由基的生成，增强机体的免疫力、抗癌和防衰老。
3、淮山：淮山(CommonYamRhizome)含甘露聚糖(mannan)、3，4-二羟基苯乙胺、植酸、尿囊素、胆碱、多巴胺、山药碱，以及10余种氨基酸、糖蛋白、多酚氧化酶；味甘，性平：归脾，肺，肾经。具有补脾养胃，生津益肺，补肾涩精功效；主治：脾虚食少、久泻不止、肺虚喘咳、肾虚遗精、带下、尿频、虚热消渴。
4、枸杞子：枸杞子(LyciumchinenseMillervar.potaninii(Pojarkova)A.M.Lu)性味甘平，无毒.入肝肾经；具有滋肝，养肝明目的功效，可以改善肝肾不足，干涩眼病；同时具有增加白细胞活性、促进肝细胞新生的药理作用，增强抵抗力；改善血压、降血糖、血脂，食少乏力，益气健胃；安神养血，益智，强筋骨，泽肌肤，驻颜色；补虚，长肌肉，益颜色，肥健入，抗疲劳。
5、红枣：红枣富含蛋白质、脂肪、糖类、胡萝卜素、B族维生素、维生素C、维生素P以及钙、磷、铁和环磷酸腺苷等营养成分；其中维生素C的含量在果品中名列前茅，有维生素王之美称；具有补中益气，健脾胃，养血安神、缓和药性的功效；
6、陈皮：陈皮味苦、辛，性温；归肺、脾经；具有理气健脾，燥湿化痰功效；主治：用于脘腹胀满，食少吐泻，咳嗽痰多。
7、罗汉果：罗汉果(Siraitiagrosvenori)含非糖甜味的成分，主要是三萜甙类：罗汉果甙V及IV，甙V的甜度是蔗糖的256-344倍，甙IV的甜度为蔗糖的126倍，没有甙IV则不呈甜味；次要的是D-甘露醇，其甜度为蔗糖的0.55-0.65倍。还含大量葡萄糖，果糖占14％。又含锰、铁、镍、硒、锡、碘、钼等26种无机元素、蛋白质、维生素C等。种仁含油脂41.07％，基中脂肪酸有：亚油酸，油酸，棕榈酸，硬脂酸，棕榈油酸，肉豆蔻酸，月桂酸，癸酸。罗汉果的干果含糖30％左右，蛋白质10％左右，每100克果实中含有维生素C100毫克。其果仁含油量高达40％，而且其中主要是油酸和亚油酸，约占70％左右。罗汉果味甘，入肺、脾二经。功能：清肺润肠。主治百日咳、痰火咳嗽，血燥便秘。甜苷最大的优点是热量极低，理化性能稳定，水溶性好，无任何毒副作用，适合所有人群长期食用，尤其适合糖尿病人、肥胖者、高血压患者等不适于食糖群体作为调味、补助品。
8、龙眼肉：龙眼肉归脾而能益智，具有养心安神，长智敛汗，开胃益脾。
9、金银花：金银花(LoniceraJaponica)味甘，微苦，清香，性辛，寒；归肺，胃，心，大肠经。具有清热解毒，疏散风热，凉血止痢，降血降火，消咽利膈之功效。对多种致病菌如金黄色葡萄球菌、溶血性链球菌、大肠杆菌、痢疾杆菌、霍乱弧菌、伤寒杆菌、副伤寒杆菌等均有一定抑制作用；对肺炎球菌、脑膜炎双球菌、绿脓杆菌、结核杆菌、志贺氏痢疾杆菌、变形链球菌等有抑菌和杀菌作用，对流感病毒、孤儿病毒、疱疹病毒、钩端螺旋体均有抑制作用；抗炎解毒作用，对痈肿疔疮、肠痈肺痈有较强的散痈消肿，清热解毒、消炎作用；对外感风热或温病初起，身热头痛、心烦少寐、神昏舌绛、咽干口燥等有一定作用；对热毒痢疾、下痢脓血、湿温阻喉、咽喉肿痛等有解毒止痢凉血利咽之效。具有清热解毒、疏散风热的作用。金银花有清热解毒、疏利咽喉、消暑除烦的作用。
10、银杏叶：银杏树的叶，主要包括黄酮类、萜内脂类化合物成分，这些成分具有强烈的抗氧化作用，可以起到清除人体内过剩的自由基、阻止体内脂质过氧化、提高人体免疫力等作用，是治疗心脑血管疾病的天然药物，可以部分或全部代替银杏叶提取物。提取的黄酮醇(内脂)、异黄酮、鼠素糖、木聚糖等产品是重要的医药原料和保健产品。
11、鸡蛋：鸡蛋几乎含有人体必需的所有营养物质，如蛋白质、脂肪、卵黄素、卵磷脂、维生素和铁、钙、钾，被人们称作“理想的营养库”。蛋白中还含有一定量的核黄素、尼克酸、生物素和钙、磷、铁等物质，卵磷脂。蛋黄含有丰富的维生素A和维生素D，且含有较高的铁、磷、硫和钙等矿物质。鸡蛋味甘；性平。归肺；脾；胃经。滋阴润燥；养血发胎。主热病烦闷；燥咳声哑；目赤咽痛；胎动不安；产后口渴；下痢；疟疾；烫伤；皮炎；虚人赢弱。.健脑益智、保护肝脏、防治动脉硬化、预防癌症、延缓衰老、美容护肤。
12、葡萄：葡萄(Vitisvinifera)味甘微酸、性平，具有补肝肾、益气血、开胃力、生津液和利小便之功效。葡萄含有人体所不可缺少的谷氨酸、精氨酸、色氨酸等十几种氨基酸，糖量高达10-30％，以葡萄糖为主，葡萄中的果酸有助于消化，葡萄中含酒石酸有助消化。葡萄汁可以降低血液中的蛋白质和氯化钠的含量。葡萄汁对体弱的病人、血管硬化和肾炎病人的康复有辅助疗效，葡萄是水果中含复合铁元素最多的水果，是贫血患者的营养食品。常食葡萄对神经衰弱者和过度疲劳者均有益处。
13、百香果(Pas-sifloraedulissims)性温，味苦，无毒，入心、大肠二经；具有百香果宁心安神、活血止痛、涩肠止泻、除风清热，止咳化痰功效，用于神经痛，失眠症，风热头昏，月经痛及下痢等症，有麻醉及镇静作用。
14、酸梅：乌梅别为蔷薇科落叶乔木植物梅(Prunusmume)的果实。果实含枸橼酸(citricacid)，苹果酸(malicacid)，草酸(oxalicacid)，琥珀酸(succinicacid)和延胡索酸(fumaricacid)总酸量约4-5.5％，以前两种有机酸的含量较多。还含5-羟甲基-2-糠醛(5-hydroxymethyl-2-furaldehyde)，为无色油状物。所含挥发性成分，主要有苯甲醛(benzaldehyde)62.40％，4-松油烯醇(terpinen-4-ol)3.97％，苯甲醇(benzylalcohol)3.97％和十六烷酸(hexadecanoicacid)4.55％。乌梅还含苦味酸(picricacid)和超氧化物歧化酶(SOD)。具有保护肠胃、消除便秘、增进食欲、改善肝脏机能、防老化、清血、可软化血管，推迟血管硬化、孕妇止吐、解酒功能、增加能量、能预防疾病、防老抗衰及消除疲劳的功能。乌梅提取物也可作为天然防腐剂。
15、杨桃：杨桃所含的大量糖类、维生素、有机酸等，是人体生命活动的重要物质，常食之，可补充机体营养，增强机体的抗病能力。性寒，味甘，酸；归肺经。具有清热、生津、利水、解毒功效，适用于风热咳嗽、咽喉疼痛，小便热涩，泌尿系统结石，心血管疾病，肥胖，痔疮，口腔溃疡。
16、皇帝柑：皇帝柑(HuangDigan)又称“贡柑”。皇帝柑乃橙与橘的自然杂交种，具有橙与橘的双重优点，具有排毒抗癌、理气化痰的作用，对癌瘤积毒、气逆痰滞癌症患者尤为适用。
17、胡萝卜：胡萝卜(Daucuscarota)含有丰富的类胡萝卜素、可溶性糖、淀粉、纤维素、多种维生素以及多种矿质元素，素有“小人参”之称。性味：味甘、辛，性温，无毒。主治足下气调补中焦，利胸膈和肠胃，安五脏，增强食欲，β-胡萝卜素是维生素A源，水解后形成维生素A，是人体不可缺少的一种维生素，可促进生长发育，维持正常视觉，防治夜盲症、干眼病、上呼吸道疾病，又能保证上皮组织细胞的健康，防治多种类型上皮肿瘤的发生和发展。而且其他类型的胡萝卜素和类胡萝卜素作为天然的有机大分子，可以清除血液及肠道的氧自由基，达到排毒、防癌、防治心血管疾病的功效。
18：果醋：果醋味酸，苦，性温，主入肝经血分，具有收敛、解毒、散瘀止痛、矫味的作用。果醋是由水果原料经酒精发酵和醋酸发酵制成的具有酯香和果香的醋。因兼有水果和食醋中的维生素、果胶、有机酸、氨基酸等营养成分，而具有许多水果和食醋共有的生理保健功能。其酸性成分能疏通软化血管，杀灭病菌，增强人体的免疫和抗病毒能力，改善消化系统，清洗消化道，有助排除关节、血管及内脏器官的毒素，调节内分泌，具有明显降低血脂和排毒保健功能。醋里的大量维生素、抗氧化剂能促进新陈代谢，美白杀菌、淡化黑色素、迅速消除老化角质、补充肌肤养分及水分，活血化瘀、缩小粗糙毛孔，抗氧化，防止色斑、可令皮肤更加光滑细腻，发质柔顺。果醋还可使人体内过多的脂肪转移为体能消耗，并促进人体糖和蛋白质的代谢，故能控制和调节体重。果醋中含有十种以上的有机酸和人体所需的多种氨基酸，它们使有氧代谢顺畅，有利于清除沉积的乳酸，起到消除疲劳的作用。
19、白糖：白糖性平，味甘，润肺生津、补中益气、清热燥湿、化痰止咳、解毒醒酒、降浊怡神；可用于治疗中虚脘痛、脾虚泄泻、肺燥咳嗽、口干燥渴以及脚气、疥疮、盐卤中毒、阴囊湿疹等病症。此外，白糖有抑菌防腐的作用。
20、蜂蜜：蜂蜜性平，味甘，归肺、脾、大肠经。补中、润燥、止痛、解毒，用于脘腹虚痛，肺燥干咳，肠燥便秘。是一种营养丰富的天然滋养食品，也是最常用的滋补品之一。蜂蜜含有与人体血清浓度相近的多种无机盐和维生素、铁、钙、铜、锰、钾、磷等多种有机酸和有益人体健康的微量元素，以及果糖、葡萄糖、淀粉酶、氧化酶、还原酶等，具有滋养、润燥、解毒之功效。蜂蜜能改善血液的成分，促进心脑和血管功能，因此经常服用对于心血管病人很有好处；蜂蜜对肝脏有保护作用，能促使肝细胞再生，对脂肪肝的形成有一定的抑制作用；蜂蜜具有迅速补充体力，消除疲劳，增强对疾病的抵抗力的作用；蜂蜜还有杀菌的作用，经常食用蜂蜜，不仅对牙齿无妨碍，还能在口腔内起到杀菌消毒的作用；蜂蜜能治疗中度的皮肤伤害，特别是烫伤，将蜂蜜当做皮肤伤口敷料时，细菌无法生长；蜂蜜具有改善睡眠、润肠通便的作用。
21、牛磺酸：牛磺酸在机体的细胞和体液免疫及抗肿瘤上都发挥着积极作用。其具有保护淋巴细胞并可促进其增殖、产生抗体的作用，还可促进巨噬细胞产生白细胞介-1。此外，牛磺酸与中性粒细胞的吞噬杀菌功能密切相关，在机体的防御机制中起重要作用。既能提高抗疲劳能力，又能提高机体的运动能力。
与现有技术相比，本技术方案具有的有益效果：
1、本技术方案将营养丰富并具有食用疗效的新鲜水果汁、蜂蜜和果醋蛋发酵液，根据传统中医中药理论加入绞股蓝、山楂叶、银杏叶、淮山、枸杞子、红枣、陈皮、罗汉果、山银花等中药提取液和牛磺酸协同作用，加强保健饮料的人体健康有益的蛋白质、糖、纤维素、多种维生素、果胶、有机酸、氨基酸和微量元素等成分和吸收，其营养丰富，酸甜可口，集保健和营养于一体，对养肝明目、活血化淤、健脑益智、保护肝脏、防治动脉硬化、抗病毒、延缓衰老、消除疲劳、降血压、降血脂、降尿酸、防癌抗癌起到积极的作用，经过应用试验证明，具有较好的保健效果，在养肝明目、健脑益智、延缓衰老、消除疲劳、防治动脉硬化、防癌、抗癌、三高人群八类人群试用中，加快疗效或显效，一天一瓶组总有效率达80～85％，一天二瓶组总有效率达85～95％，一天三瓶组总有效率达90～100％。
2、本发明的工艺简单，成本低廉，产品安全、无毒副作用，而且食用方便，具有较好的经济效益和社会效益。
具体实施方式
下面实施例对本发明进一步说明，但是本发明的保护范围不仅仅局限于以下具体实施例。
实施例1：
原料组分和重量份数为：
水果葡萄7公斤、百香果6公斤、鲜鸡蛋12公斤、绞股蓝1.5公斤、山楂叶2.5公斤、淮山4公斤、枸杞子1.3公斤、红枣1.9公斤、陈皮1.5公斤、罗汉果2.3公斤、龙眼肉1.9公斤、金银花1.9公斤、银杏叶4公斤、苹果醋7公斤、白糖15公斤、蜜糖1.9公斤、牛磺酸1.9公斤、山梨酸钾0.48公斤、干酵母0.5公斤、甜酒粉0.2公斤、灭菌泉水25公斤。
制备方法：
先将12公斤鲜鸡蛋洗净外壳，再将鲜鸡蛋打烂，蛋液打散备用，将蛋壳捻碎加入苹果醋2公斤，待蛋壳醋渍24小时后，加入蛋液和干酵母0.2公斤，拌匀，发酵后，在121℃高压灭菌30min，取出用匀浆机掏碎，再加入苹果醋5公斤、适量灭菌泉水及干酵母0.3公斤，拌匀，封盖，控制温度40℃，发酵48小时后，加入甜酒粉0.2公斤，拌匀，继续在40℃温度下发酵62小时，过滤，得到蛋钙液。另将绞股蓝1.5公斤、山楂叶2.5公斤、淮山4公斤、枸杞子1.3公斤、红枣1.9公斤、陈皮1.5公斤、罗汉果2.3公斤、龙眼肉1.9公斤、金银花1.9公斤、银杏叶4公斤分别去杂，水洗，切碎，加入原料组分总重量的7倍灭菌泉水，在蒸煮罐中煎煮2小时后过滤，药渣加入原料组分总重量的4倍灭菌泉水复煮1.5小时后过滤，合并滤液，按常规方法浓缩至1倍药材量，放置沉淀槽中静置过夜，取上清液得到中药提取液。又另将葡萄7公斤、百香果6公斤洗净，除去泥沙等杂物，再用螺杆挤压机绞碎成果泥，加入余下灭菌泉水，搅匀，用高速离心机120目过滤，得到鲜果汁。
将上述制备的蛋钙液、中药提取液和鲜果汁合并，再加入白糖15公斤、蜜糖1.9公斤、牛磺酸1.9公斤、山梨酸钾0.48公斤，拌匀，经胶体磨均质，常规方法灭菌，过滤，分装即得到果汁蛋钙中药保健饮料产品。
实施例2：
原料组分和重量份数为：
水果酸梅5公斤、杨桃5公斤、胡萝卜5公斤、鲜鸡蛋11公斤、中药绞股蓝1公斤、山楂叶2公斤、淮山3公斤、枸杞子1公斤、红枣1.8公斤、陈皮1公斤、罗汉果2.2公斤、龙眼肉1.8公斤、金银花1.8公斤、银杏叶3公斤、辅料果醋6公斤、白糖16公斤、蜜糖1.8公斤、牛磺酸1.8公斤、山梨酸钾0.45公斤、干酵母0.4公斤、甜酒粉0.3公斤、灭菌泉水15公斤。
制备方法：
先将鲜鸡蛋11公斤洗净外壳，再将鲜鸡蛋打烂，蛋液打散备用，将蛋壳捻碎加入果醋1公斤，待蛋壳醋渍24小时后，加入蛋液和干酵母0.2公斤，拌匀，发酵后，在121℃高压灭菌30min，取出用匀浆机掏碎，再加入苹果醋5公斤、少量灭菌泉水及干酵母0.2公斤，拌匀，封盖，控制温度40℃，发酵48小时后，加入甜酒粉0.2公斤，拌匀，继续在40℃温度下发酵72小时，过滤，得到蛋钙液。另将绞股蓝1公斤、山楂叶2公斤、淮山3公斤、枸杞子1公斤、红枣1.8公斤、陈皮1公斤、罗汉果2.2公斤、龙眼肉1.8公斤、金银花1.8公斤、银杏叶3公斤分别去杂，水洗，切碎，加入原料组分总重量的6-8倍灭菌泉水，在蒸煮罐中煎煮1-2小时后过滤，药渣加入原料组分总重量的3-5倍灭菌泉水复煮1-1.5小时后过滤，合并滤液，按常规方法浓缩至1倍药材量，放置沉淀槽中静置过夜，取上清液得到中药提取液。又另将酸梅5公斤、杨桃5公斤、胡萝卜5公斤洗净，除去泥沙等杂物，再用螺杆挤压机绞碎成果泥，加入余下灭菌泉水，搅匀，用高速离心机120目过滤，得到鲜果汁。
将上述制备的蛋钙液、中药提取液和鲜果汁合并，再加入白糖16公斤、蜜糖1.8公斤、牛磺酸1.8公斤、山梨酸钾0.45公斤，拌匀，经胶体磨均质，常规方法灭菌，过滤，分装即得到果汁蛋钙中药保健饮料产品。
实施例3：
原料组分和重量份数为：
水果葡萄5公斤、胡萝卜5公斤、海鸭蛋13公斤、中药绞股蓝2公斤、山楂叶3公斤、淮山5公斤、枸杞子1.5公斤、红枣2公斤、陈皮2公斤、罗汉果2.4公斤、龙眼肉2公斤、金银花2公斤、银杏叶5公斤、辅料果醋8公斤、白糖14公斤、蜜糖2公斤、牛磺酸2公斤、山梨酸钾0.5公斤、干酵母0.6公斤、甜酒粉0.3公斤、灭菌泉水35公斤。
制备方法：
先将海鸭蛋13公斤洗净外壳，再将鲜鸡蛋打烂，蛋液打散备用，将蛋壳打碎加入果醋2公斤，待蛋壳醋渍24小时后，加入蛋液和干酵母0.4公斤，拌匀，发酵后，在121℃高压灭菌30min，取出用匀浆机掏碎，再加入苹果醋6公斤、少量灭菌泉水及干酵母0.4公斤，拌匀，封盖，控制温度40℃，发酵48小时后，加入甜酒粉0.2公斤，拌匀，继续在40℃温度下发酵62小时，过滤，得到蛋钙液。另将绞股蓝2公斤、山楂叶3公斤、淮山5公斤、枸杞子1.5公斤、红枣2公斤、陈皮2公斤、罗汉果2.4公斤、龙眼肉2公斤、金银花2公斤、银杏叶5公斤分别去杂，水洗，切碎，加入原料组分总重量的7倍灭菌泉水，在蒸煮罐中煎煮2小时后过滤，药渣加入原料组分总重量的5倍灭菌泉水复煮1.5小时后过滤，合并滤液，按常规方法浓缩至0.8倍药材量，放置沉淀槽中静置过夜，取上清液得到中药提取液。又另将葡萄5公斤、胡萝卜5公斤洗净，除去泥沙等杂物，再用螺杆挤压机绞碎成果泥，加入余下灭菌泉水，搅匀，用高速离心机120目过滤，得到鲜果汁。
将上述制备的蛋钙液、中药提取液和鲜果汁合并，再加入白糖14公斤、蜜糖2公斤、牛磺酸2公斤、山梨酸钾0.5公斤，拌匀，经胶体磨均质，常规方法灭菌，过滤，分装即得到果汁蛋钙中药保健饮料产品。
实施例4：
原料组分和重量份数为：
水果皇帝柑5公斤、胡萝卜10公斤、鲜鸡蛋12公斤、中药绞股蓝1.6公斤、山楂叶2.3公斤、淮山3.5公斤、枸杞子1.3公斤、红枣2公斤、陈皮1.6公斤、罗汉果2.4公斤、龙眼肉1.8公斤、金银花1.8公斤、银杏叶5公斤、辅料自制苹果醋7.5公斤、白糖14.5公斤、蜜糖2公斤、牛磺酸2公斤、山梨酸钾0.5公斤、干酵母0.6公斤、甜酒粉0.3公斤、灭菌泉水30公斤。
制备方法：
先将鲜鸡蛋12公斤洗净外壳，再将鲜鸡蛋打烂，蛋液打散备用，将蛋壳捻碎加入自制苹果醋2.5公斤，待蛋壳醋渍24小时后，加入蛋液和干酵母0.3公斤，拌匀，发酵后，在121℃高压灭菌30min，取出用匀浆机掏碎，再加入自制苹果醋5公斤、少量灭菌泉水及干酵母0.3公斤，拌匀，封盖，控制温度40℃，发酵48小时后，加入甜酒粉0.3公斤，拌匀，继续在40℃温度下发酵62小时，过滤，得到蛋钙液。另将绞股蓝1.6公斤、山楂叶2.3公斤、淮山3.5公斤、枸杞子1.3公斤、红枣2公斤、陈皮1.6公斤、罗汉果2.4公斤、龙眼肉1.8公斤、金银花1.8公斤、银杏叶5公斤分别去杂，水洗，切碎，加入原料组分总重量的6.5倍灭菌泉水，在蒸煮罐中煎煮1.5小时后过滤，药渣加入原料组分总重量的4倍灭菌泉水复煮1.5小时后过滤，合并滤液，按常规方法浓缩至1.2倍药材量，放置沉淀槽中静置过夜，取上清液得到中药提取液。又另将皇帝柑5公斤、胡萝卜10公斤洗净，除去泥沙等杂物，再用螺杆挤压机绞碎成果泥，加入余下灭菌泉水，搅匀，用高速离心机120目过滤，得到鲜果汁。
将上述制备的蛋钙液、中药提取液和鲜果汁合并，再加入白糖14.5公斤、蜜糖2公斤、牛磺酸2公斤、山梨酸钾0.5公斤，拌匀，经胶体磨均质，常规方法灭菌，过滤，分装即得到果汁蛋钙中药保健饮料产品。
上述自制果醋的制备方法是将苹果4公斤，沥干水分，切成小块，置干净玻璃瓶中，加砂糖2公斤及糯米醋2公斤，摇匀，密封置于阴凉干燥处，一周后取出，用100目滤布过滤即得自制苹果醋。
产品应用试验情况：
本产品对养肝明目、健脑益智、延缓衰老、消除疲劳、防治动脉硬化、防癌、抗癌、三高人群八类人群进行饮用试验。每个试用组均为20人，各类人群设一天一瓶一组、一天二瓶一组、一天三瓶一组。试用期均为30天，每10天查询记录保健效果一次。其效果分加快疗效或显效进程。其中一天一瓶组总有效率80～85％，一天二瓶组总有效率85～95％，一天三瓶组总有效率90～100％。试用结果见汇总表。
应用试验结果汇总表
典型实例：
实例1：
陈X：男，31岁，血压偏高，有头痛感，不服降压药，自2014年6月21日起饮用本果汁蛋钙中药保健饮料，坚持1天2瓶，分早晚各饮1瓶。饮用14天后头痛感消失，饮用28天后到医院检查血压正常，现坚持每天早上饮1瓶，半年检查血压1次均正常，无头痛感出现，保健效果好。
实例2：
潭XX：男，65岁，患皮肤癌，服药治疗，自2014年7月6日起配合治疗饮用本果汁蛋钙中药保健饮料，1天3瓶，分早中晚各饮1瓶，饮用21天后皮肤小痘缩小，饮用30天后皮肤小痘消失，到医院检查已恢复正常，不再服药，但坚持每天早晚各饮1瓶，半年后检查均正常，保健效果好。
实例3：
郭X：女，48岁，体质弱，容易疲劳，自2014年7月12日起饮用本果汁蛋钙中药保健饮料，1天2瓶，分早晚各饮1瓶，饮用10天后，身体的疲劳感消除，体力恢复快，10天后坚持每天晚饮1瓶，保健效果好，无疲劳感。
实例4：
林XX：女，53岁，身体正常，但容易忘记事件，自2014年6月24日起饮用本果汁蛋钙中药保健饮料，1天2瓶，分早晚各饮1瓶，饮用14天后，记益力有所提高，饮用28天后，记益力恢复正常，无忘事现象，以后坚持每天晚上饮用1瓶，健脑益智效果好。
实例5：
彭X：男，46岁，身体正常，但视力减退，自2014年7月9日起饮用本果汁蛋钙中药保健饮料，1天3瓶，分早中晚各饮1瓶，饮用21天后，视力提高，饮用30天后，视力恢复正常状态，30天后坚持每天早上饮用1瓶，保健效果好。
Claims (10)
1.一种果汁蛋钙中药保健饮料，主要由水果、禽蛋、中药及辅料制成，所述水果的重量份数为10-15份，所述禽蛋的重量份数为11-13份，所述中药的重量份数分别为：绞股蓝1-2份、山楂叶2-3份、淮山3-5份、枸杞子1-1.5份、红枣1.8-2份、陈皮1-2份、罗汉果2.2-2.4份、龙眼肉1.8-2份、金银花1.8-2份、银杏叶3-5份，所述辅料的重量份数分别为：果醋6-8份、白糖14-16份、蜜糖1.8-2份、牛磺酸1.8-2份、山梨酸钾0.45-0.5份、干酵母0.4-0.6份、甜酒粉0.1-0.3份、灭菌泉水15-35份。
2.根据权利要求1所述的一种果汁蛋钙中药保健饮料，其特征在于：原料组分和重量份数为：水果13份、禽蛋12份、绞股蓝1.5份、山楂叶2.5份、淮山4份、枸杞子1.3份、红枣1.9份、陈皮1.5份、罗汉果2.3份、龙眼肉1.9份、金银花1.9份、银杏叶4份、果醋7份、白糖15份、蜜糖1.9份、牛磺酸1.9份、山梨酸钾0.48份、干酵母0.5份、甜酒粉0.2份、灭菌泉水25份。
3.根据权利要求1或2所述的一种果汁蛋钙中药保健饮料，其特征在于：所述水果为葡萄、百香果、酸梅、杨桃、皇帝柑、胡萝卜一种以上。
4.根据权利要求1或2所述的一种果汁蛋钙中药保健饮料，其特征在于：所述果醋为市售果醋或自制的果醋。
5.根据权利要求1或2所述的一种果汁蛋钙中药保健饮料，其特征在于：所述禽蛋为新鲜鸡蛋、海鸭蛋。
6.根据权利要求1所述的一种果汁蛋钙中药保健饮料，其特征在于：先将所述的原料组分和重量份数分类制成蛋钙液、中药提取液和鲜果汁，将蛋钙液、中药提取液和鲜果汁合并，再加入白糖14-16份、蜜糖1.8-2份、牛磺酸1.8-2份、山梨酸钾0.45-0.5份，搅拌溶解，再加入余下的灭菌泉水，搅匀，经胶体磨均质，常规方法灭菌，过滤，分装即得到果汁蛋钙中药保健饮料产品。
7.根据权利要求6所述的一种果汁蛋钙中药保健饮料，其特征在于：所述蛋钙液的制备方法是将11-13份禽蛋洗净，再将禽蛋打烂，禽蛋液打散备用，将禽蛋壳捻碎加入果醋2-3份，待蛋壳醋渍24小时后，加入蛋液和干酵母0.1-0.2份，拌匀，发酵后，在121℃高压灭菌30min，取出用匀浆机掏碎，再加入果醋4-5份、适量灭菌泉水及干酵母0.2-0.4份，拌匀，封盖，控制温度40℃，发酵48小时后，加入甜酒粉0.1-0.3份，拌匀，继续在40℃温度下发酵48-72小时，过滤，得到蛋钙液。
8.根据权利要求6所述的一种果汁蛋钙中药保健饮料，其特征在于：所述中药提取液的制备方法是将绞股蓝1-2份、山楂叶2-3份、淮山3-5份、枸杞子1-1.5份、红枣1.8-2份、陈皮1-2份、罗汉果2.2-2.4份、龙眼肉1.8-2份、金银花1.8-2份、银杏叶3-5份分别去杂，水洗，切碎，加入原料组分总重量的6-8倍灭菌泉水，在蒸煮罐中煎煮1-2小时后过滤，药渣加入原料组分总重量的3-5倍灭菌泉水复煮1-2小时后过滤，合并滤液，按常规方法浓缩至0.5-1倍药材量，放置沉淀槽中静置过夜，取上清液得到中药提取液。
9.根据权利要求6所述的一种果汁蛋钙中药保健饮料，其特征在于：所述鲜果汁的制备方法是将葡萄、百香果、酸梅、杨桃、皇帝柑、胡萝卜等一种以上共10-15份，洗净，除去泥沙等杂物，再用螺杆挤压机绞碎成果泥，加入灭菌泉水10-12份，搅匀，高速离心机120目过滤，得到鲜果汁。
10.根据权利要求4所述的一种果汁蛋钙中药保健饮料，其特征在于：所述自制果醋是将苹果1份洗净，沥干水分，切成小块，置干净玻璃瓶中，加砂糖0.5份及糯米醋0.5份，摇匀，密封置于阴凉干燥处，一周后取出，用100目滤布过滤即得自制苹果醋。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510325950.6A CN105029553A (zh) | 2015-06-15 | 2015-06-15 | 一种果汁蛋钙中药保健饮料及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510325950.6A CN105029553A (zh) | 2015-06-15 | 2015-06-15 | 一种果汁蛋钙中药保健饮料及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105029553A true CN105029553A (zh) | 2015-11-11 |
Family
ID=54436998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510325950.6A Pending CN105029553A (zh) | 2015-06-15 | 2015-06-15 | 一种果汁蛋钙中药保健饮料及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105029553A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105851760A (zh) * | 2016-04-14 | 2016-08-17 | 福建胜华农业科技发展有限公司 | 一种具有降低尿酸功效的固体饮料及其制作方法 |
| CN106418036A (zh) * | 2016-09-27 | 2017-02-22 | 临沂大学 | 一种缓解体力疲劳的保健饮料及其制备方法 |
| CN111567756A (zh) * | 2020-06-04 | 2020-08-25 | 东北农业大学 | 一种蔬菜复合醋蛋液制品及其制备方法 |
| CN113974040A (zh) * | 2021-11-15 | 2022-01-28 | 杭州裕善源科技有限公司 | 一种保健饮料 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1097575A (zh) * | 1994-05-03 | 1995-01-25 | 忻州市国营食品酿造厂 | 醋蛋浆饮品及其制备方法 |
| CN1459233A (zh) * | 2003-04-03 | 2003-12-03 | 宁洁民 | 醋蛋保健酸奶及制备方法 |
| KR20090038692A (ko) * | 2007-10-16 | 2009-04-21 | 전라북도 고창군 | 복분자를 이용한 식초음료 및 그의 제조방법 |
| CN101926462A (zh) * | 2010-08-06 | 2010-12-29 | 冯兵 | 蜂蜜醋蛋保健液的制备方法 |
| CN103099273A (zh) * | 2012-12-13 | 2013-05-15 | 陈显贵 | 蜂蜜醋蛋液花生露功能保健饮料 |
-
2015
- 2015-06-15 CN CN201510325950.6A patent/CN105029553A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1097575A (zh) * | 1994-05-03 | 1995-01-25 | 忻州市国营食品酿造厂 | 醋蛋浆饮品及其制备方法 |
| CN1459233A (zh) * | 2003-04-03 | 2003-12-03 | 宁洁民 | 醋蛋保健酸奶及制备方法 |
| KR20090038692A (ko) * | 2007-10-16 | 2009-04-21 | 전라북도 고창군 | 복분자를 이용한 식초음료 및 그의 제조방법 |
| CN101926462A (zh) * | 2010-08-06 | 2010-12-29 | 冯兵 | 蜂蜜醋蛋保健液的制备方法 |
| CN103099273A (zh) * | 2012-12-13 | 2013-05-15 | 陈显贵 | 蜂蜜醋蛋液花生露功能保健饮料 |
Non-Patent Citations (2)
| Title |
|---|
| 孔保华: "《畜产品加工储存新技术》", 31 May 2007, 科学出版社 * |
| 赖建平，等: "新鲜鸡蛋饮料的研究和制作", 《食品科学》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105851760A (zh) * | 2016-04-14 | 2016-08-17 | 福建胜华农业科技发展有限公司 | 一种具有降低尿酸功效的固体饮料及其制作方法 |
| CN106418036A (zh) * | 2016-09-27 | 2017-02-22 | 临沂大学 | 一种缓解体力疲劳的保健饮料及其制备方法 |
| CN111567756A (zh) * | 2020-06-04 | 2020-08-25 | 东北农业大学 | 一种蔬菜复合醋蛋液制品及其制备方法 |
| CN113974040A (zh) * | 2021-11-15 | 2022-01-28 | 杭州裕善源科技有限公司 | 一种保健饮料 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100551250C (zh) | 保健茶 | |
| CN102422941B (zh) | 一种草珊瑚清爽型凉茶（饮料）及其制备方法 | |
| KR101433188B1 (ko) | 아미노산, 활성종합비타민 및 한방생약재를 함유하는 숙취해소용 조성물 및, 그 제조방법 | |
| KR101541516B1 (ko) | 누에와 뽕나무잎과 상지(桑枝)를 주원료로한 이온미네랄 건강음료의 제조방법 | |
| CN105112265A (zh) | 一种保健无花果酒及其制作方法 | |
| CN103229875B (zh) | 三花暖茶饮料及其生产方法 | |
| CN105087279A (zh) | 一种保健南瓜酒及其制作方法 | |
| CN110897147A (zh) | 铁皮石斛解酒保肝组合物和制法 | |
| KR101578070B1 (ko) | 발모 촉진, 탈모 완화 및 개선, 혈당 조절, 위장 장애 증상 완화 및 개선용 건강보조식품 | |
| CN105029553A (zh) | 一种果汁蛋钙中药保健饮料及其制备方法 | |
| CN103238889B (zh) | 一种抗疲劳苹果醋保健饮料及其制备方法 | |
| CN106617049A (zh) | 一种含辣木叶提取物的蜂胶类保健品及其制备方法 | |
| CN110226688A (zh) | 一种桑葚黄精饮品及其制备方法 | |
| CN101828738A (zh) | 防治糖尿病的保健饮料 | |
| CN107557204B (zh) | 一种混酿荔枝玫瑰酒及其制备方法 | |
| CN107557254B (zh) | 一种荔枝玫瑰酒和制备方法及补益气血与抗氧化应用 | |
| CN106923115A (zh) | 含西红花的植物饮料及其制备方法和应用 | |
| CN104017715A (zh) | 一种百香果醋及其制作方法 | |
| CN104431125A (zh) | 一种沙棘蜂蜜茶及其制备方法 | |
| KR100773889B1 (ko) | 액상본초추출물을 유효성분으로 포함하는 숙취해소용 조성물 및 그 제조방법 | |
| CN107384680B (zh) | 一种百香果龙眼果酒及其酿造方法 | |
| CN105176773A (zh) | 一种调节血糖的南瓜酒及其制作方法 | |
| CN104435648A (zh) | 一种食药两用的组合物及其用途和制备方法 | |
| US20100247670A1 (en) | Red Grape Dry Composition and Health Tea | |
| CN102787048A (zh) | 一种龙葵果保健型酒的酿制方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151111 |
|
| WD01 | Invention patent application deemed withdrawn after publication |